Literature DB >> 8341524

Coverage strategies in total joint replacement.

B Chandrasekhar1, W Brien.   

Abstract

The strategy for soft-tissue management following total joint arthroplasty begins with prevention. The medical status of the patient is optimized preoperatively. Meticulous surgical technique with liberalized indication for flap closure primarily will reduce soft-tissue failures. Early identification and aggressive team management of complications are critical to decrease long-term morbidity and to obtain a good functional result.

Entities:  

Mesh:

Year:  1993        PMID: 8341524

Source DB:  PubMed          Journal:  Orthop Clin North Am        ISSN: 0030-5898            Impact factor:   2.472


  5 in total

Review 1.  Wound complications in total knee arthroplasty. Which flap is to be used? With or without retention of prosthesis?

Authors:  Alfredo Schiavone Panni; Michele Vasso; Simone Cerciello; Marzia Salgarello
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-12-15       Impact factor: 4.342

Review 2.  [Soft tissue defects as a complication in knee arthroplasty. Surgical strategies for soft tissue reconstruction].

Authors:  L Kovacs; A Zimmermann; P Juhnke; C Taskov; N A Papadopulos; E Biemer
Journal:  Orthopade       Date:  2006-02       Impact factor: 1.087

3.  Angiographic findings in patients with postoperative soft tissue defects following total knee arthroplasty.

Authors:  Christian Herold; Andreas Steiert; Karsten Knobloch; Marc N Busche; Mehmet A Altintas; Peter M Vogt
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-05-25       Impact factor: 4.342

Review 4.  [Quadriceps tendon insufficiency and rupture : Treatment options in total knee arthroplasty].

Authors:  K Thiele; P von Roth; T Pfitzner; B Preininger; C Perka
Journal:  Orthopade       Date:  2016-05       Impact factor: 1.087

5.  Flaps for closure of soft tissue defects in infected revision knee arthroplasty.

Authors:  Arnold J Suda; Angela Cieslik; Paul A Grützner; Matthias Münzberg; Volkmar Heppert
Journal:  Int Orthop       Date:  2014-03-25       Impact factor: 3.075

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.